Saved in:
| Format: | Book |
|---|---|
| Published: |
dic. 2005
|
| Online Access: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005001200011&lng=pt&nrm=iso&tlng=es |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1869362456328929284 |
|---|---|
| building | Biblioteca Facultad de Medicina |
| format | Book |
| fullrecord | oai:netcat:be-dblil-85
BR1.1
LILACS
LILACSEXPRESS
MEDLINE
SP
as
Internet
<i>http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005001200011&lng=pt&nrm=iso&tlng=es</i>
Nuevos receptores nucleares heterodimÚricos: reguladores metabólicos con impacto en fisiopatologÝa y su proyección terapÚutica en dislipidemias y diabetes mellitus
New heterodimeric nuclear receptors: key metabolic regulators with relevance in the pathophysiology and therapy of dyslipidemias and diabetes mellitus
Rev. mÚd. Chile
133
12
0034-9887
ilus
tab
Es
En
Fondo Nacional de Desarrollo CientÝfico y Tecnológico de Chile
1030416
dic. 2005
20051200
57
The regulation of gene expression is crucial for the normal development and the homeostatic maintenance of body tissues. Thus, its malfunction may determine a variety of human disease conditions. A growing body of evidence has shown the overwhelming relevance of a new class of gene expression regulators: the heterodimeric nuclear receptors, a family of structurally related proteins involved in multiple biological functions. In response to activating ligands, these molecules bind to specific genomic regulatory regions where they can coordinately modify the transcriptional activity of several genes involved in the main metabolic pathways of lipids and carbohydrates in cells. These functional properties have stimulated the study of the relationships between heterodimeric nuclear receptors and various disease conditions, such as dyslipidemias and diabetes mellitus. Here we review the experimental, clinical and epidemiological evidences that support the relevance of these transcriptional regulators in the pathophysiology of the most prevalent and lethal diseases in Western countries. We also explore the potential therapeutic impact of new strategies based in the pharmacological modulation of the heterodimeric nuclear receptors.(AU)
2006-06-09
20060531
SCIELO
JA
FONTE
428533
<d>BIREME_LXP</d>
<s>S0034-98872005001200011</s>
CortÚs, VÝctor
<s1>Pontificia Universidad Católica de Chile</s1>
<s2>Facultad de Medicina</s2>
<s3>Departamentos de GastroenterologÝa</s3>
<c>Santiago</c>
<p>Chile</p>
Quezada, Nicolßs
<s1> Pontificia Universidad Católica de Chile</s1>
<c>Santiago</c>
<p>Chile</p>
Rigotti, Attilio
<s1>Pontificia Universidad Católica de Chile</s1>
<s2>Facultad de Medicina</s2>
<s3>Departamentos de GastroenterologÝa</s3>
<c>Santiago</c>
<p>Chile</p>
Maiz, Alberto
<s1>Pontificia Universidad Católica de Chile</s1>
<s2>Facultad de Medicina</s2>
<s3>Departamento de Nutrición, Diabetes y Metabolismo</s3>
<c>Santiago</c>
<p>Chile</p>
<f>1483</f>
<l>1492</l>
85
|
| id | oai:netcat:be-dblil-85 |
| institution | UMSS |
| publishDate | dic. 2005 |
| record_format | abcd |
| spellingShingle | Registro ABCD - ID: oai:netcat:be-dblil-85 |
| title | Registro ABCD - ID: oai:netcat:be-dblil-85 |
| url | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005001200011&lng=pt&nrm=iso&tlng=es |